BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Covington
Farmers Insurance
US Army
Fish and Richardson
Medtronic
McKesson
Colorcon
Queensland Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022556

« Back to Dashboard

NDA 022556 describes KARBINAL ER, which is a drug marketed by Tris Pharma Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the KARBINAL ER profile page.

The generic ingredient in KARBINAL ER is carbinoxamine maleate. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
Summary for 022556
Tradename:KARBINAL ER
Applicant:Tris Pharma Inc
Ingredient:carbinoxamine maleate
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 022556
Suppliers and Packaging for NDA: 022556
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556 NDA Avadel Pharmaceuticals (USA), Inc. 13551-101 13551-101-01 2 BOTTLE, PLASTIC in 1 CARTON (13551-101-01) > 30 mL in 1 BOTTLE, PLASTIC
KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556 NDA Avadel Pharmaceuticals (USA), Inc. 13551-101 13551-101-05 480 mL in 1 BOTTLE, PLASTIC (13551-101-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION, EXTENDED RELEASE;ORALStrength4MG/5ML
Approval Date:Mar 28, 2013TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Mar 29, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Jun 15, 2027Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Citi
AstraZeneca
Argus Health
Federal Trade Commission
Boehringer Ingelheim
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot